[ASND] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
28-Nov-2018
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 5.86%
YoY- 6.43%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 4,897 535 2,507 10,515 280 1,043 1,977 16.30%
PBT -106,176 -138,982 -80,400 -32,066 -34,361 -16,426 -12,249 43.27%
Tax -114 -17 -38 -88 -186 22 -254 -12.48%
NP -106,062 -138,965 -80,362 -31,978 -34,175 -16,448 -11,995 43.75%
Tax Rate - - - - - - - -
Total Cost 110,959 139,500 82,869 42,493 34,455 17,491 13,972 41.20%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -2,165.86 -25,974.77 -3,205.50 -304.12 -12,205.36 -1,576.99 -606.73 23.60%
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -1.97 -2.60 -1.68 -0.76 -0.92 -0.51 -0.48 26.50%
EPS Diluted -1.97 -2.58 -1.67 -0.74 -0.88 -0.51 -0.48 26.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.